A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: selatinib ditosilate tablets
Sponsor: Qilu Pharmaceutical Co., Ltd.